Aleksandar Danilovski

Director/Board Member presso ACTIVE BIOTECH AB

50 anni

Health Technology

Consumer Services

Retail Trade

Profilo

Aleksandar Danilovski is currently an Independent Director at Active Biotech AB and a Director at Pharmaero ApS.
He also serves as the Chief Scientific Officer at Xellia Pharmaceuticals ApS since 2009.
Previously, he held positions as a Principal at PLIVA, Inc., Head-European Research & Development at Barr Laboratories, Inc., and Member-Management Board at PLIVA Pharmaceuticals, Inc. He was also a Principal at The Barr Group, Inc. and a Member-Management Board at PLIVA Croatia Ltd.
from 2011 to 2012.
Additionally, he served as a Member-Scientific Selection Board at Novo Holdings A.
Danilovski obtained a doctorate degree from the University of Cambridge and holds undergraduate and doctorate degrees from the University of Zagreb.

Posizioni attive di Aleksandar Danilovski

Società	Posizione	Inizio
ACTIVE BIOTECH AB	Director/Board Member	01/01/2020
Xellia Pharmaceuticals ApS Xellia Pharmaceuticals ApS Pharmaceuticals: MajorHealth Technology Xellia Pharmaceuticals ApS manufactures pharmaceutical products. Its products include pharmaceutical ingredients, finished dosage forms and novel anti infective pipeline. The company was founded in 1959 and is headquartered in Copenhagen, Denmark.	Chief Tech/Sci/R&D Officer	01/01/2020
Pharmaero ApS	Director/Board Member	-

Tutte le posizioni attive di Aleksandar Danilovski

Precedenti posizioni note di Aleksandar Danilovski

Società	Posizione	Fine
PLIVA Pharmaceuticals, Inc.	Corporate Officer/Principal	-
Barr Laboratories, Inc. Barr Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Barr Laboratories, Inc. develops and markets generic pharmaceuticals. The company was founded by Edwin A. Cohen in 1970 and is headquartered in Montvale, NJ.	Corporate Officer/Principal	-
Novo Holdings A/S (Investment Company) Novo Holdings A/S (Investment Company) Financial ConglomeratesFinance Novo Holdings A/S (Investment Company) (Novo Holdings-IC) is the investment portfolio division of Novo Holdings A/S, a holding company headquartered in Hellerup, Denmark. They are ultimately owned by Novo Nordisk Fonden (Novo Nordisk Foundation). Founded in 1999, Novo Holdings-IC manages a broad portfolio of the Foundation’s financial assets.	Corporate Officer/Principal	-
PLIVA Croatia Ltd.	Director/Board Member	-
The Barr Group, Inc.	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di Aleksandar Danilovski

Formazione di Aleksandar Danilovski

University of Cambridge	Doctorate Degree
University of Zagreb	Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Aleksandar Danilovski

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
ACTIVE BIOTECH AB	Health Technology

Aziende private	8
PLIVA, Inc. PLIVA, Inc. Drugstore ChainsRetail Trade PLIVA, Inc. develops, produces, and sells drugs and pharmaceutical products. Its products include Ethosuximide, Fluoxetine, and Cyclosporine. The company was founded in 1921 and is headquartered in East Hanover, NJ.	Retail Trade
Barr Laboratories, Inc. Barr Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Barr Laboratories, Inc. develops and markets generic pharmaceuticals. The company was founded by Edwin A. Cohen in 1970 and is headquartered in Montvale, NJ.	Health Technology
PLIVA Pharmaceuticals, Inc.
Xellia Pharmaceuticals ApS Xellia Pharmaceuticals ApS Pharmaceuticals: MajorHealth Technology Xellia Pharmaceuticals ApS manufactures pharmaceutical products. Its products include pharmaceutical ingredients, finished dosage forms and novel anti infective pipeline. The company was founded in 1959 and is headquartered in Copenhagen, Denmark.	Health Technology
The Barr Group, Inc.
PLIVA Croatia Ltd.
Novo Holdings A/S (Investment Company) Novo Holdings A/S (Investment Company) Financial ConglomeratesFinance Novo Holdings A/S (Investment Company) (Novo Holdings-IC) is the investment portfolio division of Novo Holdings A/S, a holding company headquartered in Hellerup, Denmark. They are ultimately owned by Novo Nordisk Fonden (Novo Nordisk Foundation). Founded in 1999, Novo Holdings-IC manages a broad portfolio of the Foundation’s financial assets.	Finance
Pharmaero ApS

Vedi le connessioni aziendali